Crestline Management, LP Insmed Inc Transaction History

Crestline Management, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 15, 2018	SELL	$21.69 - $32.99 $1.49 Million - $2.27 Million	-68,856 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$26.43 - $31.78 $90,839 - $109,227	3,437 Added 5.25%	68,856 $2.15 Million
Q3 2017 Nov 14, 2017	BUY	$11.61 - $31.21 $759,514 - $2.04 Million	65,419	65,419 $2.04 Million

490

188M

3.04M

3.15M

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $10.7B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

Get notified when there are updates to the investment portfolio of Crestline Management, LP, based on Form 13F filings with the SEC.

Stay updated on Crestline Management, LP with notifications on news.